Logo image of USA.CA

AMERICAS GOLD AND SILVER COR (USA.CA) Stock Fundamental Analysis

Canada - TSX:USA - CA03062D8035 - Common Stock

4.14 CAD
+0.28 (+7.25%)
Last: 9/19/2025, 7:00:00 PM
Fundamental Rating

3

Overall USA gets a fundamental rating of 3 out of 10. We evaluated USA against 808 industry peers in the Metals & Mining industry. Both the profitability and financial health of USA have multiple concerns. While showing a medium growth rate, USA is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

USA had negative earnings in the past year.
USA had a negative operating cash flow in the past year.
USA had negative earnings in each of the past 5 years.
USA had a negative operating cash flow in each of the past 5 years.
USA.CA Yearly Net Income VS EBIT VS OCF VS FCFUSA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

USA has a Return On Assets (-24.42%) which is comparable to the rest of the industry.
USA has a Return On Equity of -106.01%. This is in the lower half of the industry: USA underperforms 66.21% of its industry peers.
Industry RankSector Rank
ROA -24.42%
ROE -106.01%
ROIC N/A
ROA(3y)-21.76%
ROA(5y)-29.6%
ROE(3y)-67.54%
ROE(5y)-77.36%
ROIC(3y)N/A
ROIC(5y)N/A
USA.CA Yearly ROA, ROE, ROICUSA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

USA has a better Gross Margin (11.89%) than 86.63% of its industry peers.
USA's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for USA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 11.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y43.19%
USA.CA Yearly Profit, Operating, Gross MarginsUSA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

2

2. Health

2.1 Basic Checks

USA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for USA has been increased compared to 1 year ago.
Compared to 5 years ago, USA has more shares outstanding
Compared to 1 year ago, USA has an improved debt to assets ratio.
USA.CA Yearly Shares OutstandingUSA.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
USA.CA Yearly Total Debt VS Total AssetsUSA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

USA has an Altman-Z score of -0.71. This is a bad value and indicates that USA is not financially healthy and even has some risk of bankruptcy.
USA's Altman-Z score of -0.71 is in line compared to the rest of the industry. USA outperforms 40.22% of its industry peers.
USA has a Debt/Equity ratio of 1.09. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.09, USA is not doing good in the industry: 75.50% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.09
Debt/FCF N/A
Altman-Z -0.71
ROIC/WACCN/A
WACC9.02%
USA.CA Yearly LT Debt VS Equity VS FCFUSA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 1.14 indicates that USA should not have too much problems paying its short term obligations.
With a Current ratio value of 1.14, USA perfoms like the industry average, outperforming 44.80% of the companies in the same industry.
USA has a Quick Ratio of 1.03. This is a normal value and indicates that USA is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.03, USA perfoms like the industry average, outperforming 45.92% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 1.03
USA.CA Yearly Current Assets VS Current LiabilitesUSA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

6

3. Growth

3.1 Past

USA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -75.00%.
The Revenue has been growing slightly by 5.49% in the past year.
The Revenue has been growing by 11.40% on average over the past years. This is quite good.
EPS 1Y (TTM)-75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)5.49%
Revenue growth 3Y30.77%
Revenue growth 5Y11.4%
Sales Q2Q%-14.86%

3.2 Future

The Earnings Per Share is expected to grow by 30.30% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 31.17% on average over the next years. This is a very strong growth
EPS Next Y86.34%
EPS Next 2Y43.99%
EPS Next 3Y32.97%
EPS Next 5Y30.3%
Revenue Next Year15.24%
Revenue Next 2Y48.83%
Revenue Next 3Y42.05%
Revenue Next 5Y31.17%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
USA.CA Yearly Revenue VS EstimatesUSA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M 400M
USA.CA Yearly EPS VS EstimatesUSA.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 0.5 -0.5

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for USA. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 118.68 indicates a quite expensive valuation of USA.
86.01% of the companies in the same industry are more expensive than USA, based on the Price/Forward Earnings ratio.
USA is valuated expensively when we compare the Price/Forward Earnings ratio to 22.86, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 118.68
USA.CA Price Earnings VS Forward Price EarningsUSA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
USA.CA Per share dataUSA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
USA's earnings are expected to grow with 32.97% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.99%
EPS Next 3Y32.97%

0

5. Dividend

5.1 Amount

USA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AMERICAS GOLD AND SILVER COR

TSX:USA (9/19/2025, 7:00:00 PM)

4.14

+0.28 (+7.25%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-11 2025-08-11/bmo
Earnings (Next)11-05 2025-11-05
Inst Owners28.61%
Inst Owner ChangeN/A
Ins Owners24.03%
Ins Owner ChangeN/A
Market Cap1.13B
Analysts80
Price Target4.51 (8.94%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)150%
PT rev (3m)253.34%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-33.34%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.88%
Revenue NY rev (3m)-13.9%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 118.68
P/S 8.18
P/FCF N/A
P/OCF N/A
P/B 14.47
P/tB 14.47
EV/EBITDA N/A
EPS(TTM)-0.48
EYN/A
EPS(NY)0.03
Fwd EY0.84%
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0.51
BVpS0.29
TBVpS0.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.42%
ROE -106.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 11.89%
FCFM N/A
ROA(3y)-21.76%
ROA(5y)-29.6%
ROE(3y)-67.54%
ROE(5y)-77.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y43.19%
F-Score2
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 1.09
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 115.82%
Cap/Sales 27.22%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 1.03
Altman-Z -0.71
F-Score2
WACC9.02%
ROIC/WACCN/A
Cap/Depr(3y)88.58%
Cap/Depr(5y)98.19%
Cap/Sales(3y)20.94%
Cap/Sales(5y)26.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y86.34%
EPS Next 2Y43.99%
EPS Next 3Y32.97%
EPS Next 5Y30.3%
Revenue 1Y (TTM)5.49%
Revenue growth 3Y30.77%
Revenue growth 5Y11.4%
Sales Q2Q%-14.86%
Revenue Next Year15.24%
Revenue Next 2Y48.83%
Revenue Next 3Y42.05%
Revenue Next 5Y31.17%
EBIT growth 1Y-78.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1732.34%
EBIT Next 3YN/A
EBIT Next 5Y146.33%
FCF growth 1Y-2.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y30.55%
OCF growth 3YN/A
OCF growth 5YN/A